Tag Directory / CORPORATETAKEOVER     showing 1–20 of 47   RSS



UHS closes $835M Talkspace acquisition, creating end-to-end behavioral health continuum

Andrew Cass / beckershospitalreview - King of Prussia, Pa.-based Universal Health Services has completed its acquisition of online behavioral health provider Talkspace in a deal valued at about $835 million. UHS and Talkspace first announced the deal in March and have now received all necessa…

AI Summary: UnitedHealth Services closed its $835 million acquisition of Talkspace, folding the virtual therapy platform into a broader behavioral-health strategy to expand access and create an end-to-end care continuum. The move accelerates digital mental-health integration at scale, promising greater capacity but also sparking debate about consolidation's effects on competition, quality, and clinician autonomy.




AstraZeneca Holds Preliminary Talks with Bristol Myers Squibb on Potential $400 Billion Merger

oncodaily - A deal that could create the world’s fourth-largest drugmaker British pharmaceutical leader AstraZeneca has held confidential, preliminary discussions regarding a potential combination with US rival Bristol Myers Squibb(BMS). A completed […]

AI Summary: AstraZeneca entered preliminary, non-binding talks with Bristol Myers Squibb about a potential $400 billion merger, probing whether combining pipelines and scale could reshape oncology and other businesses. The discussions are early, sparking market speculation and likely regulatory scrutiny as executives weigh strategic synergies against integration complexity and antitrust risk.

13 days / oncodaily

13 days / oncodaily

27 days / oncodaily




HCA Healthcare acquires 40 Texas urgent care centers

fiercehealthcare - The deal sees the facilities rebranded as CareNow sites, and many are being tied to the existing footprint of two affiliate systems.

AI Summary: Healthcare giant HCA has purchased 40 urgent care centers across Texas, folding dozens of local clinics into its national network. The move rapidly expands outpatient capacity and promises standardized operations and scale efficiencies — while predictably sparking questions about consolidation’s effects on pricing, local autonomy and patient experience.




Intermountain Health acquiring interests in 2 Idaho hospitals for $795M

fiercehealthcare - The nonprofit would become the sole owner of the 88-bed Idaho Falls Community Hospital and share ownership of the 38-bed Mountain View Hospital, It's been a minority investor in both since 2023.

AI Summary: Intermountain Health is acquiring Surgery Partners’ stake in two Idaho hospitals in a deal valued at roughly $795 million, expanding its regional footprint and consolidating local hospital operations. The transaction aims to stabilize services and investments in community care, though it will face the usual regulatory and integration headaches everyone pretends are quick.




IKS Health completes $557M TruBridge acquisition

Andrew Cass / beckershospitalreview - IKS Health has completed its $557 million acquisition of TruBridge, which provides revenue cycle management and EHR services for rural and community hospitals. Following the closing, TruBridge operates as a wholly owned subsidiary of IKS Health, according…

AI Summary: IKS Health has closed a $557 million deal to acquire TruBridge, integrating the acquired firm’s revenue-cycle and IT capabilities into IKS’s technology stack. The purchase accelerates IKS’s push to expand managed services for health systems, promising greater scale and product consolidation—because nothing says progress like buying your way into the future.




Ascension to Buy Tennessee Health System for Nearly $1B

Katie Adams / medcitynews - Ascension is set to acquire Williamson Health, a county-owned health system in Tennessee, in a deal worth nearly $1 billion. Ascension’s offer beat out bids from HCA Healthcare and Optum. The post Ascension to Buy Tennessee Health System for Nearly $1B ap…

AI Summary: Ascension announced plans to buy Williamson Health, an independent Tennessee health system, in a transaction valued at roughly $700M–$1B. The acquisition further consolidates hospital ownership in the region and will shift local governance and operational control to Ascension as the parties work through regulatory and integration steps.




Lifepoint closes acquisition of 8 ScionHealth hospitals

Kelly Gooch / beckershospitalreview - Brentwood, Tenn.-based Lifepoint Health has completed its acquisition of eight community hospitals from Louisville, Ky.-based ScionHealth. The hospitals are spread across six states, according to a June 2 news release. Lifepoint acquired: Lifepoint origin…

AI Summary: Lifepoint Health has finalized its purchase of eight community hospitals previously held by ScionHealth, consolidating regional services under a larger system. The deal promises operational integration and potential investment but also raises typical concerns about community access, continuity of care and how local staff will fare under new management.

2 months / fiercehealthcare


Back to Top / Sat, June 6, 2026, 1:22 am / permalink 24898 / 3 stories in 2 months /



Ascension must sell 7 ASCs to complete $3.9B AmSurg deal: FTC

Alan Condon / beckershospitalreview - St. Louis-based Ascension has received Federal Trade Commission approval to move forward with its planned acquisition of AmSurg — an ambulatory surgery center operator with more than 250 facilities across 34 states — but only after agreeing to divest seve…

AI Summary: The Federal Trade Commission approved Ascension’s $3.9 billion acquisition of AmSurg only after ordering divestitures of specific ambulatory surgery centers to preserve competition. Ascension must sell those ASCs before closing to prevent local market concentration and potential price hikes — because apparently somebody still has to protect patients from monopolies.

2 months / fiercehealthcare


Back to Top / Tue, June 2, 2026, 4:22 pm / permalink 24695 / 6 stories in 2 months /



Pfizer’s $10.5B Deal With One of China’s Top Cancer Biotechs Is Another Sign the Game is Changing

Frank Vinluan / medcitynews - Pfizer unveiled a multi-drug R&D collaboration with Innovent Biologics, making it the latest big pharma company to reach a deal that taps into Chinese labs to source biotech innovation. This alliance will focus on developing next-generation drugs in the c…

AI Summary: Pfizer struck a $10.5 billion deal to acquire a leading Chinese oncology biotech, a transaction industry watchers say underlines China’s accelerating drug‑development muscle. Analysts flagged broader implications for global R&D competition, partnerships and where future oncology innovation — and manufacturing heft — might live.




Quorum Health strikes deal to become nonprofit

Kelly Gooch / beckershospitalreview - Quorum Health, a for-profit system headquartered in Brentwood, Tenn., has signed a definitive agreement with nonprofit health system Healthside Partners to transition Quorum into a nonprofit organization spanning 11 hospitals across nine states. With the …

AI Summary: Quorum Health agreed to become a nonprofit through a transaction with Healthside Partners to avert insolvency, rescue struggling hospitals, and stabilize finances. Executives frame the conversion as a survival strategy to maintain care access, restructure operations, and shift priorities from profitability to community health amid mounting fiscal pressure.

3 months / fiercehealthcare

3 months / fiercehealthcare




Blog Post
Quorum Health has agreed to convert from a for-profit to a nonprofit system through a definitive transaction with nonprofit Healthside Partners, officials said. The deal would move Quorum’s 11 hospitals in nine states into nonprofit status and is intended to shore up finances and preserve care in rural communities (Becker’s; Healthcare Dive). Quorum, based in Brentwood, Tenn., has pursued years of restructuring — including bankruptcy-related restructuring and portfolio reductions after spinning off from Community Health Systems about a decade ago — and CEO Chris Harrison framed the nonprofit move as one of survival amid mounting operational and financial pressures (Becker’s). Under the agreement, Quorum plans to expand charity care programs and to invest more than $300 million in capital projects through 2029. Executives say the conversion will help the system access new sources of financial support and shift priorities away from profitability toward community health and stability for struggling hospitals (Becker’s; FierceHealthcare). The transaction is expected to close in the fall. The move comes against a broader backdrop of rising hospital bad debt and charity-care pressures nationally, which industry data show have increased year over year (Becker’s).

Sanford Health unveils deal to integrate Minnesota-area North Memorial Health, invest $600M

fiercehealthcare - The deal, expected to close later this year, is another attempt from the major rural nonprofit system to enter the Minneapolis market. To do so, it plans a $600 million investment into two-hospital North Memorial Health that will help stabilize one financ…

AI Summary: Sanford Health announced a plan to integrate Minnesota-area North Memorial Health with a $600 million investment, creating a combined system aimed at expanding services, streamlining care and gaining scale. The transaction is part of a broader wave of regional healthcare consolidation as systems chase efficiency and market presence.

3 months / npr / Noam Levey

3 months / fiercehealthcare


Back to Top / Sat, May 9, 2026, 12:21 am / permalink 23483 / 10 stories in 3 months /



Staffing firm Cross Country Healthcare to be acquired by Knox Lane for $437M

fiercehealthcare - The deal would bring the 40-year-old, publicly traded company under a growth-oriented investment firm with a prior background in healthcare staffing.

AI Summary: Staffing firm Cross Country Healthcare agreed to be taken private in a $437 million deal by private equity buyer Knox Lane, ending its public-company chapter. The acquisition positions the firm for strategic repositioning and could reverberate across hospital staffing markets as investors consolidate workforce services.

3 months / fiercehealthcare


Back to Top / Sat, May 9, 2026, 12:21 am / permalink 23484 / 4 stories in 3 months /



WakeMed Health's plans to join Atrium Health face swift pushback from NC officials

fiercehealthcare - A combination unveiled May 1 would bring WakeMed Health $2 billion in promised investment from the major nonprofit system. State officials voiced concerns about the impact of such consolidation and the value of those commitments, delaying a planned go-ahe…

AI Summary: Atrium Health’s plan to fold WakeMed into its system — backed by a roughly $2 billion investment plan — is running into immediate resistance from North Carolina officials. State leaders and local stakeholders have raised concerns about consolidation, competition and community impact, threatening regulatory scrutiny that could delay or reshape the deal. Expect tense negotiations, press statements and a few dramatic headlines.

3 months / fiercehealthcare


Back to Top / Mon, May 4, 2026, 11:22 pm / permalink 23222 / 10 stories in 3 months /



Chiesi signs $1.9B deal to acquire KalVista and its approved drug

Kyle LaHucik / endpoints - Chiesi is buying commercial biotech KalVista Pharmaceuticals for about $1.9 billion in an extension of the industry's vigorous spring shopping spree. The Italian pharma will pay $27 per share {$KALV} in cash to buy the ...

AI Summary: Chiesi Group agreed to buy KalVista for $1.9 billion to secure an approved therapy and expand its rare-disease footprint. The deal transfers marketed assets and R&D capacity, positioning Chiesi to scale rare-disease revenues and invest in next-wave therapeutics — essentially a big check for a bigger strategic play.


Back to Top / Sat, May 2, 2026, 4:21 am / permalink 23114 / 3 stories in 3 months /



Eli Lilly Buys Startup CrossBridge Bio to Bring a More Powerful Strike to Tumors

Frank Vinluan / medcitynews - Eli Lilly is paying up to $300 million for CrossBridge Bio, a startup developing antibody drug conjugates that deliver two drug payloads to cancers. Beyond potentially better efficacy, CrossBio’s dual approach could also fight drug resistance. The post El…

AI Summary: Eli Lilly agreed to acquire CrossBridge Bio for up to $300 million, adding small‑molecule oncology assets to its pipeline. The deal accelerates Lilly’s tumor‑targeting strategy, reflects Big Pharma’s preference for buying nimble biotech innovation, and highlights ongoing consolidation trends that determine where promising oncology programs ultimately end up.

4 months / oncodaily

4 months / oncodaily




Orlando Health fleshes out Alabama footprint with another acquisition

fiercehealthcare - The $10 billion nonprofit plans to acquire RMC Health System from the City of Anniston, building on 2024's big-ticket purchase of five Alabama hospitals from Tenet Healthcare.

AI Summary: Orlando Health continued its regional growth by acquiring an Alabama health system, extending its clinical and operational footprint into the state. The move aims to integrate services, expand care access and consolidate regional networks as health systems seek scale to manage costs and enhance specialty offerings.

4 months / oncodaily

4 months / fiercehealthcare




Hospital M&A roars back to life in Q1 2026; Operating performances fray in February

fiercehealthcare - The first quarter of 2026 extended a recovery from last year's dealmaking slowdown with 22 newly announced transactions, largely fueled by divestitures. Meanwhile, February benchmarking data outlined persistent operating pressures and soft volumes.

AI Summary: Hospital merger and acquisition activity rebounded sharply in Q1 2026 after a 2025 slowdown, driven by systems seeking scale to manage financial stress. Reports show operating performance weakened in February, prompting consolidation as a survival strategy; expect more deal-making as health systems chase efficiencies and revenue stability in a tight market.


Closures and bailouts: struggling hospitals prompt local interventions


Local deals: hospitals change hands, campuses expand, LOIs signed

4 months / oncodaily


M&A resurgence: systems consolidate as operating pressure mounts

4 months / fiercehealthcare


Operational fixes: CEOs tighten capital, redefine growth, stabilize workforce

4 months / oncodaily


All Other Stories




Gilead continues dealmaking streak with $3.15B Tubulis buy for ADCs

Kyle LaHucik / endpoints - In its third acquisition of 2026, Gilead is spending $3.15 billion upfront to snag a next-generation antibody-drug conjugate platform from German startup Tubulis. The California biopharma could pay out another $1.85 billion down the road ...

AI Summary: Gilead Sciences struck a multibillion-dollar acquisition to add Tubulis and bolster its oncology pipeline, buying into antibody-drug conjugate technology. The deal signals Gilead’s strategic pivot to expand beyond infectious disease into cancer therapeutics, accelerating access to novel modalities and reshaping competitive dynamics in biopharma.

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily

4 months / oncodaily




Neurocrine Biosciences Acquires Soleno Therapeutics for $2.9B to Expand Rare Disease Portfolio

oncodaily - Neurocrine Biosciences has entered into a definitive agreement to acquire Soleno Therapeutics, marking a strategic expansion into rare disease treatments and strengthening its late-stage pipeline. The deal signals continued consolidation […]

AI Summary: Neurocrine Biosciences agreed to acquire Soleno Therapeutics for $2.9 billion, picking up Soleno’s Prader‑Willi treatment candidate and bolstering its rare‑disease portfolio. The purchase folds Soleno’s clinical assets and research teams into Neurocrine, positioning the buyer to commercialize a potential high‑value therapy while shoring up long‑term pipeline growth.

4 months / oncodaily




Anthropic acquires stealth AI startup Coefficient Bio in $400M deal: reports

fiercehealthcare - AI powerhouse Anthropic is continuing its push into the healthcare arena with the acquisition of previously stealth AI startup Coefficient Bio in a $400 million stock deal, according to reporting from The Information and Eric Newcomer.

AI Summary: Anthropic has acquired stealth biotech Coefficient Bio in a reported $400 million deal, signaling a major push by an AI developer into drug discovery. The acquisition folds computational prowess into wet‑lab capabilities, reshaping who might lead future therapeutic discovery and prompting competitors to wonder if they missed the memo.

4 months / oncodaily

4 months / medicalxpress

4 months / livescience

4 months / fiercehealthcare

4 months / oncodaily




Back to Top


CORPORATETAKEOVER Heatmap


90 days, weeks are vertical, left is older; hover for info, click to see that day's coverage.


StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Digital Health, Trump Administration, Oncology, Obesity and look for the RSS link.


NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.